Episode Details

Over 200 deaths and 158,000 adverse reactions linked to popular weight-loss injections like Mounjaro, Wegovy, Ozempic, and Saxenda are now under review — but regulators stress these are suspected connections, not confirmed causes. While numbers are alarming, officials remind listeners that millions of prescriptions are still being issued, and benefits currently outweigh risks for approved uses. Safety is being closely monitored, with updates promised if new risks emerge.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/59d9ad79382a9aa9